Publications by authors named "Axel Bellotti"

Claim this Profile
A
An ISR-independent role of GCN2 prevents excessive ribosome biogenesis and mRNA translation.
Mónica Román-Trufero, Istvan T Kleijn, Kevin Blighe, Jinglin Zhou, Paula Saavedra-García, Axel Bellotti

Life Sci Alliance· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAD+ metabolism restriction boosts high-dose melphalan efficacy in patients with multiple myeloma.
Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Axel Bellotti

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage migration inhibitory factor blockade reprograms macrophages and disrupts prosurvival signaling in acute myeloid leukemia.
Caroline Spertini, Alexandre P Bénéchet, Flora Birch, Axel Bellotti, Mónica Román-Trufero

Cell Death Discov· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia.
Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Michel A Duchosal, Aimable Nahimana

Cancers (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new FK866 analogues with potent anticancer activity against pancreatic cancer.
Jian-Fei Bai, Somi Reddy Majjigapu, Bernard Sordat, Sophie Poty, Pierre Vogel, Axel Bellotti

Eur J Med Chem· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia.
Oussama ElMokh, Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Karin Schaeuble

Cell Death Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Anne-Julie Cloux, Dominique Aubry, Mathieu Heulot, Christian Widmann, Oussama ElMokh, Axel Bellotti

Oncotarget· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periostin Limits Tumor Response to VEGFA Inhibition.
Ioanna Keklikoglou, Ece Kadioglu, Stefan Bissinger, Benoît Langlois, Axel Bellotti

Cell Rep· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis